Age Shapes Melanoma Spread, Scientists Discover
Study Conducted at Fox Chase Cancer Center
According to НВ — Техно: June 1, 7:00 PM
New research from Fox Chase Cancer Center, unveiled at the American Association for Cancer Research annual meeting, reveals that melanoma behaves differently across age groups due to the activity of gamma-delta T cells. The lowest tumor spread was observed in young mice, while the highest rates occurred in middle-aged animals. Interestingly, in very old mice, the spread of tumors declined again.
The Critical Role of Gamma-Delta T Cells
The findings emphasize that gamma-delta T cells are central to melanoma progression. Young and elderly mice had elevated levels of these cells, whereas middle-aged mice showed a drop in gamma-delta T cell counts. This decrease was linked to more frequent metastasis to the lungs and liver in middle-aged mice. Melanoma cells in these mice released substances that suppressed or exhausted the gamma-delta T cells.
When gamma-delta T cells were removed from young and very old mice, melanoma spread increased dramatically. Conversely, blocking signals that dampen the immune system helped reduce cancer spread in middle-aged mice. However, this blocking strategy had no effect on young or elderly animals.
As Mitchell Fain noted, 'scientists are striving to understand why cancer risk rises with age but begins to drop after age 80–85.'
This study, which zeroes in on how age alters melanoma behavior, could be a major step toward grasping cancer development mechanisms and improving treatments. While cancer risk does increase with age, it starts to decline around 80–85 years, a phenomenon that warrants further investigation.
The results highlight the importance of age as a factor in the immune response to melanoma, potentially opening up new therapeutic avenues for this cancer type. Understanding how gamma-delta T cells function across different age groups may lead to more effective prevention and treatment strategies tailored to patients' age-related characteristics.
As research continues to uncover the complexities of cancer behavior, the recent findings on melanoma spread highlight the intricate relationship between age and immune response. Similarly, a recent study has identified a protein that can effectively halt the growth of brain tumors, offering new insights into cancer treatment strategies. To learn more about this groundbreaking discovery, check out how this newly found protein impacts tumor dynamics in our detailed report regarding brain tumors.
Read also

